You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Correlates of clinical benefit from immunotherapy and targeted therapy in metastatic renal cell carcinoma: comprehensive genomic and transcriptomic analysis

Article metrics

Article menu

Download PDFPDF

XML
Immunotherapy biomarkers
Original research
Correlates of clinical benefit from immunotherapy and targeted therapy in metastatic renal cell carcinoma: comprehensive genomic and transcriptomic analysis

 

Online download statistics by month:

Online download statistics by month: July 2020 to March 2024

AbstractFullPdf
Jul 2020442442142
Aug 202023023179
Sep 202013113142
Oct 2020797936
Nov 2020535322
Dec 2020505020
Jan 2021585818
Feb 2021606022
Mar 202117917853
Apr 202116316337
May 202122222227
Jun 202112612627
Jul 202110210231
Aug 2021888830
Sep 2021878719
Oct 2021979739
Nov 2021919230
Dec 202110210421
Jan 2022989911
Feb 2022757515
Mar 2022313215
Apr 2022373919
May 2022434323
Jun 2022676825
Jul 2022868926
Aug 2022858615
Sep 202210811039
Oct 20229610229
Nov 202280808
Dec 2022838319
Jan 2023888911
Feb 2023898912
Mar 2023868714
Apr 2023737314
May 202382827
Jun 2023858513
Jul 2023848414
Aug 202377777
Sep 202379797
Oct 202379796
Nov 202382829
Dec 202312312321
Jan 2024313212
Feb 2024565715
Mar 2024969639
Total445944831140